Found 11 matching trials
De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Transplant Recipients PHASE3 This study is being done to compare the effectiveness of de novo Letermovir...
Show More Status
Active Not Recruiting
Location
VCU Medical Center
Learn More & Join Trial
A Randomized Controlled Trial of Prophylactic Rituximab to Reduce Clinically Significant EBV DNAemia After Allogeneic Hematopoietic Stem Cell Transplantation NA This is a single-center, prospective, randomized, open-label clinical trial...
Show More Location
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
Learn More & Join Trial
The Use of Cytomegalovirus Cell Mediated Immunity to Optimize the Duration of Letermovir Prophylaxis in Hematopoietic Cell Transplant Recipients NA The goal of this laboratory research study is to learn if interrupting a pa...
Show More Location
The University of Texas MD Anderson Cancer Center
Learn More & Join Trial
Letermovir for the Prevention of Cytomegalovirus Reactivation in Patients With Hematological Malignancies Treated With Alemtuzumab PHASE2 This phase II trial studies how well letermovir works for the prevention of...
Show More Location
Ohio State University Comprehensive Cancer Center
Learn More & Join Trial
Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant PHASE2 The purpose of this study is to compare the safety and efficacy of letermov...
Show More Location
NYP-Weill Cornell
Learn More & Join Trial
CMV-TCIP Directed Letermovir Prophylaxis After Allo-SCT PHASE2 This is a phase 2, prospective cohort clinical trial evaluating the utiliza...
Show More Location
Chao Family Comprehensive Cancer Center, University of California Irvine
Learn More & Join Trial
Efficacy of Letermovir in Preventing Cytomegalovirus (CMV) Infection in Lung Transplant Recipients vs. Valganciclovir. PHASE2 The goal of this quasi-experimental multicenter before-after cohort study, ...
Show More Location
Hospital Universitario Reina Sofia
Learn More & Join Trial
Clinical Trial to Evaluate the Effects of Letermovir Prophylaxis on T-cell Immune Activation in Participants With Treated HIV-1 Infection PHASE2 People living with HIV (PLWH), even with an undetectable viral load (VL) on...
Show More Location
Multiple Locations
Learn More & Join Trial
Cytomegalovirus Prophylaxis With Letermovir in Heart Transplant Recipients PHASE2 CMV infection is the most prevalent infection after heart transplantation (...
Show More Location
University Medical Center Ljubljana
Learn More & Join Trial
Letermovir Prophylaxis Duration Guided by CMV-Specific T-cell Monitoring After Allo-HSCT. PHASE4 The purpose of this study is to evaluate the efficacy and safety of a perso...
Show More Location
Chinese PLA General Hospital
Learn More & Join Trial